Department of Radiation Oncology, Sir H.N Reliance Foundation Hospital, Mumbai, Maharashtra, India.
Asian Pac J Cancer Prev. 2024 Nov 1;25(11):4043-4049. doi: 10.31557/APJCP.2024.25.11.4043.
This study aimed to report the findings of comprehensive weekly quality audit of radiotherapy procedures conducted at our institute, assessing various domains including clinical notes, contour delineation, treatment planning, prescription accuracy, patient-specific quality assurance, and treatment set-up checks.
The audit protocol, based on the Peer Review Audit Tool (PRAT) from the Royal Australian and New Zealand College of Radiologists, evaluated six critical parameters: clinical decisions, contours, treatment prescriptions, plan evaluation, plan quality assurance, and daily treatment set-ups. Patients were assessed for changes categorized as no change, minor change, or major change. The audit panel comprised radiation oncologists, medical physicists, and therapists. The audit is conducted on a weekly basis, including patients who initiated treatment within the preceding week.
Between December 2020 to October 2023, 1831 cases were treated with radiotherapy in our institution and all of them were included in the quality audit. Overall, majority of patients exhibited no changes across various domains, with minor adjustments noted in a small percentage of cases. Notably, the clinical note check domain showed 99% adherence to standards, while contour delineation and treatment planning domains displayed minor adjustments in 2.7% and 1.7% of cases, respectively. Prescription accuracy and patient-specific quality assurance demonstrated high compliance, with minimal changes observed. Treatment set-up checks revealed minor variations in 0.3% and major changes in 0.2% of cases.
This study underscores the importance of comprehensive quality audits in radiation oncology to ensure precision and consistency in treatment delivery. By identifying potential areas for improvement and maintaining high standards across all stages of the radiotherapy process, such audits play a crucial role in optimizing treatment outcomes and enhancing patient safety.
本研究旨在报告我们机构进行的放射治疗流程综合周质量审核结果,评估包括临床记录、轮廓勾画、治疗计划、处方准确性、患者特定质量保证和治疗设置检查在内的各个领域。
审核协议基于澳大利亚和新西兰皇家放射科医师学院的同行评审审核工具(PRAT),评估六个关键参数:临床决策、轮廓、治疗处方、计划评估、计划质量保证和日常治疗设置。患者的评估结果分为无变化、小变化或大变化。审核小组由放射肿瘤学家、医学物理学家和治疗师组成。审核每周进行一次,包括在前一周开始治疗的患者。
2020 年 12 月至 2023 年 10 月期间,我们机构对 1831 例患者进行了放射治疗,所有患者均纳入质量审核。总体而言,大多数患者在各个领域均无变化,少数患者有小调整。值得注意的是,临床记录检查域符合标准的比例达到 99%,而轮廓勾画和治疗计划域分别有 2.7%和 1.7%的病例有小调整。处方准确性和患者特定质量保证显示出高度的一致性,只有微小的变化。治疗设置检查显示 0.3%的病例有小变化,0.2%的病例有大变化。
本研究强调了在放射肿瘤学中进行全面质量审核的重要性,以确保治疗提供的精度和一致性。通过识别潜在的改进领域,并在放射治疗过程的所有阶段保持高标准,此类审核在优化治疗结果和增强患者安全方面发挥着关键作用。